Article info
PDFOriginal research
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice
- Correspondence to Dr Tiziana Vavala, SC of Oncology, ASL CN1, Saluzzo (Cuneo), Italy; tvavala{at}gmail.com
Citation
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice
Publication history
- Received December 12, 2020
- Revised January 9, 2021
- Accepted January 12, 2021
- First published January 28, 2021.
Online issue publication
March 17, 2022
Article Versions
- Previous version (28 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.